CHRM2 Antibody
Cat# MBS8583692-0,1mL-AF647
Size : 0.1mL(AF647)
Brand : MyBiosource
CHRM2 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8583692MBS8583692 is an antibody targeting CHRM2. Also known as CHRM2 Antibody. Reactive in Human, Mouse, Rat, Bovine, Pig. Host: Rabbit. Rabbit polyclonal antibody to CHRM2 More details
Product Overview
Online Datasheet in PDFProduct Name
CHRM2, Polyclonal Antibody
Full Product Name
CHRM2 Antibody
Product Gene Name
anti-CHRM2 antibody
Product Synonym Names
Muscarinic acetylcholine receptor M2
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Bovine, Pig
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of CHRM2 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
51,715 Da
Chromosome Location
Chromosome: 7; NC_000007.13 (136553399..136701771). Location: 7q31-q35
OMIM
103780
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human CHRM2. The exact sequence is proprietary.
Product Categories/Family for anti-CHRM2 antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-CHRM2 antibody
Western Blot (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)
Application Notes for anti-CHRM2 antibody
WB: 1:500-1:1000
IHC: 1:50-1:200
IHC: 1:50-1:200
Other Notes
Small volumes of anti-CHRM2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for CHRM2. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
muscarinic acetylcholine receptor M2
NCBI Official Synonym Full Names
cholinergic receptor, muscarinic 2
NCBI Official Symbol
CHRM2
NCBI Official Synonym Symbols
HM2
UniProt Protein Name
Muscarinic acetylcholine receptor M2
Protein Family
Muscarinic acetylcholine receptor
UniProt Gene Name
CHRM2
UniProt Entry Name
ACM2_HUMAN
NCBI Protein Information
muscarinic acetylcholine receptor M2; 7TM receptor; muscarinic M2 receptor; acetylcholine receptor, muscarinic 2; cholinergic receptor, muscarinic 2, isoform a
NCBI Summary for CHRM2
The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine to these receptors and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 2 is involved in mediation of bradycardia and a decrease in cardiac contractility. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for CHRM2
mAChR M2: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is adenylate cyclase inhibition. Genetic variations in CHRM2 can influence susceptibility to major depressive disorder (MDD). MDD is one of the most common psychiatric disorders. MDD is a complex trait characterized by one or more major depressive episodes without a history of manic, mixed, or hypomanic episodes. A major depressive episode is characterized by at least 2 weeks during which there is a new onset or clear worsening of either depressed mood or loss of interest or pleasure in nearly all activities. Four additional symptoms must also be present including changes in appetite, weight, sleep, and psychomotor activity; decreased energy; feelings of worthlessness or guilt; difficulty thinking, concentrating, or making decisions; or recurrent thoughts of death or suicidal ideation, plans, or attempts. The episode must be accompanied by distress or impairment in social, occupational, or other important areas of functioning. Belongs to the G-protein coupled receptor 1 family. Muscarinic acetylcholine receptor subfamily. CHRM2 sub-subfamily.
Protein type: Membrane protein, integral; Membrane protein, multi-pass; Receptor, GPCR; GPCR, family 1
Chromosomal Location of Human Ortholog: 7q31-q35
Cellular Component: postsynaptic membrane; integral to plasma membrane; plasma membrane; cell junction
Molecular Function: G-protein coupled acetylcholine receptor activity
Biological Process: G-protein signaling, coupled to cAMP nucleotide second messenger; nervous system development; G-protein coupled receptor protein signaling pathway; G-protein signaling, coupled to cyclic nucleotide second messenger; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); acetylcholine receptor signaling, muscarinic pathway; response to virus; regulation of heart contraction; muscarinic acetylcholine receptor, phospholipase C activating pathway
Show more Protein type: Membrane protein, integral; Membrane protein, multi-pass; Receptor, GPCR; GPCR, family 1
Chromosomal Location of Human Ortholog: 7q31-q35
Cellular Component: postsynaptic membrane; integral to plasma membrane; plasma membrane; cell junction
Molecular Function: G-protein coupled acetylcholine receptor activity
Biological Process: G-protein signaling, coupled to cAMP nucleotide second messenger; nervous system development; G-protein coupled receptor protein signaling pathway; G-protein signaling, coupled to cyclic nucleotide second messenger; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); acetylcholine receptor signaling, muscarinic pathway; response to virus; regulation of heart contraction; muscarinic acetylcholine receptor, phospholipase C activating pathway
Research Articles on CHRM2
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-CHRM2 antibody
| Reference Product | PubMed Publications |
|---|---|
| GRK5 antibody | >1 publications with CHRM2 and GRK5 |
| GNG2 antibody | >1 publications with CHRM2 and GNG2 |
Pathways associated with anti-CHRM2 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Amine Ligand-binding Receptors Pathway antibodies | Amine Ligand-binding Receptors Pathway Diagram |
| Arf6 Trafficking Events Pathway antibodies | Arf6 Trafficking Events Pathway Diagram |
| Calcium Regulation In The Cardiac Cell Pathway antibodies | Calcium Regulation In The Cardiac Cell Pathway Diagram |
| Calcium Signaling Pathway antibodies | Calcium Signaling Pathway Diagram |
| Calcium Signaling Pathway antibodies | Calcium Signaling Pathway Diagram |
| Cholinergic Synapse Pathway antibodies | Cholinergic Synapse Pathway Diagram |
| Class A/1 (Rhodopsin-like Receptors) Pathway antibodies | Class A/1 (Rhodopsin-like Receptors) Pathway Diagram |
| G Alpha (i) Signalling Events Pathway antibodies | G Alpha (i) Signalling Events Pathway Diagram |
| GPCR Downstream Signaling Pathway antibodies | GPCR Downstream Signaling Pathway Diagram |
| GPCR Ligand Binding Pathway antibodies | GPCR Ligand Binding Pathway Diagram |
Diseases associated with anti-CHRM2 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Substance-Related Disorders Antibodies | >20 publications with CHRM2 and Substance-Related Disorders |
| Death Antibodies | >3 publications with CHRM2 and Death |
| Cognition Disorders Antibodies | >3 publications with CHRM2 and Cognition Disorders |
| Memory Disorders Antibodies | >3 publications with CHRM2 and Memory Disorders |
| Nervous System Diseases Antibodies | >2 publications with CHRM2 and Nervous System Diseases |
| Inflammation Antibodies | >2 publications with CHRM2 and Inflammation |
| Pain Antibodies | >1 publications with CHRM2 and Pain |
| Immune System Diseases Antibodies | >1 publications with CHRM2 and Immune System Diseases |
| Tremor Antibodies | >1 publications with CHRM2 and Tremor |
| Arrhythmias, Cardiac Antibodies | >1 publications with CHRM2 and Arrhythmias, Cardiac |


